94 Trending Stocks

Tue, Nov 24, 2020

Regeneron Pharmaceuticals

REGN 508.12
15.49 (3.0%)

Open: 521.61 High: 528.44 Low: 508.00

9 x 508.12 = 4573.08
x $508.12 =

NASDAQ: REGN $55 Billion Large-Cap. Nasdaq 100. S&P 500. Health Care Sector. Biotech & Pharma Industry. 5 Year Return 10%. 1 Year Return 39%. 2020 YTD Return 36%. Since Earnings 22%.

ST

External Links

Free Channels & more...

For Starters

Charts

image
image

52WL $331.57

The 52 Week Low is $331.57 set on Thu, Jan 30, 2020.

52WH $664.64

The 52 Week High is $664.64 set on Mon, Jul 20, 2020.

ATH $664.64

The All-Time High is $664.64 set on Mon, Jul 20, 2020.

52 Week Range

$331.57
$664.64
Jan 30, 2020
Jul 20, 2020

Earnings

7.98

Earnings Per Share

24.20

Price To Earnings Ratio


Q1 Earnings for Jan, Feb & Mar

Tue, May 5, 2020

Since Q1 Earnings Report

REGN 6.2%


Q2 Earnings for Apr, May & Jun

Wed, Aug 5, 2020

Since Q2 Earnings Report

REGN 21.6%

Dividends

0.00

Dividend Yield

0.00

Dividend Rate

--

Ex-Dividend Date

--

Dividend Payment Date

--

Dividend Frequency

0

Dividend History

Profile

Regeneron Pharmaceuticals trades on the NASDAQ. REGN's market cap is 55.4 Billion.

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products including: Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Dupixent in atopic dermatitis, asthma, and nasal polyposis; Libtayo in cutaneous squamous cell carcinoma; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal antibodies with Sanofi in immunology and cancer, and bispecific antibodies and antibody cocktails with other collaborators and independently.

Website

Related Channels

Account Channels

Track your portfolio and more.